« BackNuclear Medicine and Biology
Article in Press

Synthesis and evaluation of nucleoside radiotracers for imaging proliferation

  • Graham Smith

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
    • Present address: Post-Graduate Medical Institute, University of Hull, HU6 7RX Hull, UK
  • ,
  • Roberta Sala

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Laurence Carroll

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Kevin Behan

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Matthias Glaser

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet Ltd., Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Edward Robins

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet Ltd., Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Quang-Dé Nguyen

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
  • ,
  • Eric O. Aboagye

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, W12 0NN London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 208 383 3759; fax: +44 208 383 1783.

Received 4 November 2011; received in revised form 29 November 2011; accepted 7 December 2011. published online 10 February 2012.
Corrected Proof

Abstract 

Introduction

Uncontrolled proliferation is a fundamental characteristic of cancer, and consequently, imaging of tumor proliferative status finds interest clinically both as a diagnostic tool and for evaluation of response to treatment. Positron emission tomography (PET) radiotracers based on a nucleoside core, such as 3′-[18F]fluoro-3′-deoxythymidine ([18F]FLT), have been extensively studied for this purpose. However, [18F]FLT suffers from poor DNA incorporation leading to occasional poor correlation of [18F]FLT tumor uptake with other proliferation indicators such as Ki-67 immunostaining.

Methods

N3-((1-(2-[18F]fluoroethyl)-1H-[1,2,3]-triazol-4-yl)methyl)thymidine ([18F]2) and N3-((1-(2-[18F]fluoroethyl)-1H-[1,2,3]-triazol-4-yl)methyl)-4′-thio-β-thymidine ([18F]3) were synthesized by click chemistry from [18F]fluoroethyl azide and by direct nucleophilic substitution of a tosylate precursor. Metabolic stability and phosphorylation potential of the radiotracers were evaluated in vitro and compared to [18F]FLT. Further, metabolic stability and biodistribution analysis of [18F]2 and [18F]3 were evaluated in vivo.

Results

Stable isotope standards and radiochemistry precursors were synthesized by modification of existing literature procedures. [18F]2 and [18F]3 were synthesized in a radiochemical yield of 8%–12% (end of synthesis, non-decay corrected). Both nucleosides were stable to metabolic degradation by thymidine phosphorylase, and in vivo stability analysis showed only one metabolite for [18F]3. No phosphorylation of [18F]2 could be detected in HCT116 cell homogenates, and in the same assay, only minor (∼8%) phosphorylation of [18F]3 was observed. Biodistribution in Balb/c mice indicated rapid clearance for [18F]2 and [18F]3 to a lesser extent.

Conclusions

The favorable biodistribution and metabolic profile of [18F]3 warrant further investigation as a next-generation PET proliferation marker.

Keywords: Click chemistry, Nucleosides, Proliferation, Fluorine-18, [18F]FLT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(11)00304-0

doi:10.1016/j.nucmedbio.2011.12.002

« BackNuclear Medicine and Biology